JAZZ PHARMACEUTICALS (JAZZ) Covered Calls

JAZZ PHARMACEUTICALS covered calls A specialty pharmaceutical company, which is focused on developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

You can sell covered calls on JAZZ PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for JAZZ (prices last updated Tue 4:16 PM ET):

JAZZ PHARMACEUTICALS (JAZZ) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
176.29 +0.92 153.46 187.50 263K 24 11B
Covered Calls For JAZZ PHARMACEUTICALS (JAZZ)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Aug 17 175 1.85 185.65 -5.7% -520.1%
Sep 21 175 5.40 182.10 -3.9% -36.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded on January 18, 2012 and is headquartered in Dublin, Ireland.